August 20, 2017 1:29 PM ET


Company Overview of Idera Pharmaceuticals, Inc.

Executive Profile

Vincent J. Milano

CEO, President & Director, Idera Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 7 Board Members in 7 different organizations across 5 different industries.

See Board Relationships
As of Fiscal Year 2016


Mr. Vincent J. Milano, also known as Vinnie and Vin, has been the Chief Executive Officer and President at Idera Pharmaceuticals, Inc. since December 1, 2014. Mr. Milano served as the Chief Executive Officer and President of ViroPharma Inc. from March 31, 2008 to January 24, 2014. He served as the Chief Operating Officer of ViroPharma Inc., from January 2006 to March 2008, Vice President from November 1997 to March 2008, Chief Financial Officer from November 1997 to ...

Corporate Headquarters

167 Sidney Street
Cambridge, Massachusetts 02139

United States

Phone: 617-679-5500
Fax: 617-679-5592

Board Members Memberships

Independent Director
Member of The Board of Directors
CEO, President & Director


Rider University

Other Affiliations

Annual Compensation

Total Annual Compensation$600,000

Stocks Options

All Other Compensation$31,555
Exercisable Options$1,000,000
Unexercisable Options$1,300,000
Total Number of Options$2,300,000

Total Compensation

Total Annual Cash Compensation$843,235
Total Short Term Compensation$600,000
Other Long Term Compensation$31,555
Total Calculated Compensation$1,417,015

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Idera Pharmaceuticals, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at